0001558370-25-003237 Sample Contracts

SIXTH AMENDMENT TO THE REVENUE INTEREST FINANCING AGREEMENT
Revenue Interest Financing Agreement • March 19th, 2025 • Liquidia Corp • Pharmaceutical preparations

This SIXTH AMENDMENT TO THE REVENUE INTEREST FINANCING AGREEMENT (this “Amendment”), dated as of March 17, 2025 (the “Sixth Amendment Effective Date”), is entered into by and between Liquidia Technologies, Inc., a Delaware corporation (the “Company”), and Healthcare Royalty Partners IV, L.P., a Delaware limited liability partnership, as the sole Investor and Investor Representative under the Agreement (as defined below) (the “Investor Representative”), solely with respect to certain enumerated provisions in the Agreement described herein. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement.

January 7, 2025
Commercial Manufacturing Services and Supply Agreement • March 19th, 2025 • Liquidia Corp • Pharmaceutical preparations